Skip to content

Ablaze Pharmaceuticals vs RayzeBio

Ablaze Pharmaceuticals  logo

Ablaze Pharmaceuticals

Leading the Innovative Targeted Radiotherapy Landscape in China

10 employees · est. 2021 · Shanghai, China

VS
RayzeBio logo

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 employees · est. 2020 · San Diego, United States

RayzeBio is the older company (2021 vs 2020); RayzeBio is the larger of the two.

Side-by-Side Comparison

Ablaze Pharmaceuticals RayzeBio
Founded
2021 2020 older
Headquarters
Shanghai, China San Diego, United States
Employees
10 258 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Medical Devices
Funding Stage
Series A Acquired
Total Funding
$75.00M $4.78B
Funding Rounds
1 5
Services
Not tracked yet Development of radiopharmaceutical therapies, Precision cancer treatment using actinium-225, Manufacturing of pharmaceutical products, Clinical trial capabilities, Drug discovery and development
Target Customers
Not tracked yet Cancer patients, Oncologists, Healthcare providers, Research institutions, Pharmaceutical companies
Taxonomy
PharmaceuticalsClinical-stageRadiopharmaceuticalsCancer TreatmentTargeted TherapyDrug Development +8 RadiopharmaceuticalsCancer TreatmentTargeted TherapiesRadioisotopesAlpha ParticlesActinium-225 +8
Website
ablazepharma.com rayzebio.com
Ablaze Pharmaceuticals  logo

About Ablaze Pharmaceuticals

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company founded in 2011 with a mission to revolutionize the targeted radiotherapy landscape in China. The company has garnered attention for its partnership with RayzeBio, Inc., a leading radiopharmaceutical firm based in San Diego, CA. This...

RayzeBio logo

About RayzeBio

RayzeBio, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical sectors, focusing on the development of targeted innovative radiopharmaceuticals for cancer treatment. With a mission outlined in their slogan, "Targeted innovative radiopharmaceuticals for cancer," RayzeBio...

Also comparing in this category

Comparing more than these two?

Get Ablaze Pharmaceuticals , RayzeBio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Ablaze Pharmaceuticals compare?

A PDF of Ablaze Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Ablaze Pharmaceuticals was founded in 2021, based in Shanghai, China, with 10 employees. Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company founded in 2011 with a mission to revolutionize the targeted radiotherapy landscape in China. The company has garnered attention for i. RayzeBio was founded in 2020, based in San Diego, United States, with 258 employees. RayzeBio, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical sectors, focusing on the development of targeted innovative radiopharmaceuticals for cancer treatment. With.
Ablaze Pharmaceuticals has raised $75.00M and RayzeBio $4.78B. Latest stage: Ablaze Pharmaceuticals Series A, RayzeBio Acquired.
Both work in Biotechnology and Pharmaceutical and list radiopharmaceuticals and cancer treatment among their focus areas.

Compare Ablaze Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ablaze Pharmaceuticals on 12 Sep 2024, and RayzeBio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout